Portugal, South Africa and Canada: Sanity Group strengthens and diversifies its global partner network

Vayamed GmbH_Medizinalcannabis
Berlin-based Sanity Group has signed new, exclusive supply agreements for medical cannabis with partners from Portugal, South Africa and Canada, securing further exclusive rights to around 20 high-THC cannabis flos from selected cultivars with a minimum volume of three tons per year for the brands Vayamed and AVAAY Medical. Deliveries are already scheduled to start at the end of the third quarter and beginning of the fourth quarter of 2022. In addition, further important strategic partnerships have been signed.

Sanity Group’s new partners for medicinal cannabis flos include the South African suppliers FarmaGrowers, Chroni-Co and Safri Canna, the Canadian suppliers Groupe Fuga, Habitat Life Sciences, Candre Cannabis and Miracle Valley, as well as Cannexpor Pharma from Portugal. To expand its sourcing options, Sanity Group’s medical division is also partnering with Portugal-based MHI Cultivo Medicinal, a subsidiary of MediCane Health Inc, thereby actively integrating a licensed platform for EU GMP processing of cannabis flos into its network.
To strengthen its market position in dronabinol and active ingredient development, Sanity Group has also entered into an exclusive partnership with GESLabs, a South African innovation company based in Cape Town, for the production of innovative dronabinol products and cannabis isolates.

Overall, by expanding its supplier network and establishing new innovation and value-added partnerships, Sanity Group is expanding its leading position in medical cannabis products and strengthens its pole position for the planned legalization of cannabis for adult-use in Germany.

“We looked at over 200 potential partners worldwide. In addition to product quality and process reliability, the new partners impressed us with their sustainable corporate governance and their enthusiasm for cannabis,” says Thimo V. Schmitt-Lord, Director Innovation & New Markets at Sanity Group.

About Sanity Group
Berlin-based Sanity Group aims to improve people’s quality of life through the use of cannabinoids and the endocannabinoid system. In addition to pharmaceuticals, the focus is also on wellbeing and cosmetic products based on cannabinoids. Sanity Group, founded in Berlin in 2018 by Finn Age Hänsel and Fabian Friede, includes Vayamed and AVAAY Medical (medicinal cannabis), Endosane Pharmaceuticals (finished pharmaceuticals), Belfry Medical (medical products and digital applications), VAAY (wellbeing) and This Place (natural cosmetics). Near Frankfurt am Main, Sanity Group also operates a production and processing facility for cannabis extracts. More information at

About Chroni-Co
Chroni-Co is a South African producer of high quality craft cannabis for the medical and pharmaceutical industry. The family business has been farming for over ten generations and follows the mantra: Old school values, New school visions. As dedicated preservationists of the land, the belief in living honestly, respectfully and with integrity in harmony with Mother Nature is upheld with the goal of producing the highest quality handcrafted cannabis for the medical and pharmaceutical industries to support research, and to promote non-harmful alternatives for pain management, mental health and chronic diseases. For more information, visit

About GESLabs
GESLabs is a cGMP pharmaceutical manufacturing business specializing in alkaloid and cannabinoid active pharmaceutical ingredient manufacture. Using carefully cultivated, (GACP), biomass processed through world-class technology GESLabs can deliver best-in-class active pharmaceutical ingredients for use in prescription medicines and wellness supplements. Find out more at

About SafriCanna
SafriCanna is a South African medical cannabis company focused on the cultivation, processing and export of high-grade medical cannabis flowers to international markets. It is the first and largest purpose built EU-GMP cannabis cultivator in South Africa and is on track to become the largest exporter of dry flower out of the Southern hemisphere. The company’s vision is to be the leading Southern hemisphere certified medical cannabis producer, by bringing together global best practices and unique South African advantages. SafriCanna has already established strategic distribution partnerships with the leading cannabis importers / distributors in Germany, UK, Israel and Australia. For more information, visit

About Cannexpor Pharma 
Cannexpor Pharma is an EU-based group of companies with an indoor pharmaceutical facility in Portugal that intends to supply pharma grade cannabis products to our partners and patients worldwide. Our focus is the quality of the product that we produce. Our indoor cannabis cultivation techniques and strict quality control allow us to achieve extreme purity of cannabis flowers, consistency of the selected cannabis genetics, and superior cannabinoid and terpene profiles. Find out more at

About MHI Cultivo Medicinal
Founded in 2019, Incorporated in Canada with presence in Israel, Portugal, Germany and Australia, MediCane’s seed-to-customer business model allows comprehensive monitoring and control of the cultivation process, along with subsequent medical and pharmaceutical R&D. This model includes genetic seed development, plant propagation and cultivation, manufacturing, pharmacological development, medical research, and distribution of the final products to end-users. The genetic bank contains a variety of strains that are cultivated in MediCane’s state-of-the-art greenhouses and then processed in post-harvest and manufacturing facilities under GACP and EU- GMP quality standards. The distribution of the final products to end-users is carried out through a global BTB and BTC partner network. In addition, through its EU-GMP premises in Portugal, MediCane Health Inc. provides contract manufacturing services for EU-GMP premium cannabis based preparations and substances, enabling premium pharma-grade and pharma-kraft cultivators around the world to meet the stringent European Good Manufacturing Practices standards and regulations for the health and wellbeing of patients. More information at

About FarmaGrowers
Established in 2019 in the North West Province of South Africa, FarmaGrowers specializes in the cultivation, manufacturing (curing) and exporting of Medicinal Cannabis. The vision is to provide the best quality EU GMP Medicinal Cannabis for export. FarmaGrowers aims to build lasting relationships with clients globally and be known as a market leader in a groundbreaking new industry. Leveraging the unique climate of Southern Africa as well as cutting edge technology and international experience, FarmaGrowers strives for sustainable growth and leaving an unforgettable, yet environmentally friendly footprint in the Medicinal Cannabis Industry, locally as well as internationally. For more information, visit

About Candre Cannabis
Candre Cannabis Inc., based in Sundre, Alberta, Canada, is a licensed craft cannabis producer focused on providing high-quality, in-demand cannabis products for medical and recreational use. Candre’s indoor facility built specifically for the production of premium quality cannabis is designed with 12 completely isolated grow rooms equipped with state-of-the-art technology including three tier mobile vertical grow infrastructure which triples the overall cannabis canopy. Find out more on

About Habitat Life Sciences
Canadian Habitat Life Sciences Inc. is focused on innovative, sustainable agriculture technology that is environmentally thoughtful and economical. Using cutting-edge technology and techniques, the company aims to revolutionize agriculture with an innovative approach to vertical growing and aquaponics that conserves land, water and air. Aquaponics is a production system that combines aquaculture, the cultivation of aquatic organisms, with hydroponics, the cultivation of plants in nutrient-enriched water. Habitat’s proprietary know-how and technology connects aquaculture waste streams to integrated hydroponic greenhouse infrastructure inputs resulting in an environmentally sustainable and economically profitable aquaponics system. To achieve its vision of balancing environmental stewardship with profitability in the production of both food and recreational cannabis, Habitat has assembled a team of leading edge aquaponics experts, horticultural experts, and business leaders. They believe that responsibly and sustainably grown products should not only nourish your body, they should nourish your mind, your community, and your habitat. For more information, visit

About Groupe Fuga
Groupe Fuga is a private corporation based in Stoneham, near Québec City, Canada. Philippe Laperrière is the company’s CEO. On an area of just over 8,600 square meters, Fuga grows cannabis in small batches, in living soil that is enriched with organic matter, in order to enhance its properties while favouring the health of both users and the staff. Fuga’s approach is clear and resolutely turned towards the future of this field: The company is much more interested in the entourage effect derived from the interactions with terpenes than in the race to produce cannabis with the highest THC level. 1% of the revenue is donated to the community for social projects. For more information, visit

About Miracle Valley Medicinal Alternatives
Miracle Valley is a fully operational, cultivation focused facility licensed under the Cannabis Act of Canada with the goal to provide the highest quality cannabis products available. The British Columbian based company established to produce, process, package and distribute bulk and finished cannabis to domestic and international distributors. Miracle Valley is driven by a passion for leadership and a commitment to being a world-class employer. Miracle Valley’s team combines decades of experience growing true legacy craft strains with the most advanced tech in picturesque Mission, British Columbia. Their mission: To be a top tier provider of cannabis products and set the standard for premium cannabis cultivation. For more information, visit

Picture: Shutterstock